048) along with CMV reactivation (HR 5.74, S = Zero.001) have been considerably linked to paraproteinaemia. Alemtuzumab with no CMV reactivation, nonetheless, led to a lot more paraproteinaemia, recommending an impression which is outside of CMV reactivation. Operating-system ended up being not as good in patients using paraproteinaemia (HR…[Weiterlesen]